Erratum: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential (Oncotarget. (2019) 10 (3681–3693) DOI: 10.18632/oncotarget.26978)

Balraj Singh, Vanessa N. Sarli, Hannah E. Kinne, Anna Shamsnia, Anthony Lucci

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article has been corrected: Figure 1 contains two accidental duplicate images representing MA cells growing without and with glutamine, respectively. The corrected Figure 1, obtained with independently collected new images in the laboratory, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original languageEnglish (US)
Pages (from-to)1272
Number of pages1
JournalOncotarget
Volume13
Issue number1
DOIs
StatePublished - 2022

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Erratum: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential (Oncotarget. (2019) 10 (3681–3693) DOI: 10.18632/oncotarget.26978)'. Together they form a unique fingerprint.

Cite this